Chiropractors in Smyrna, DE Accepting Medicare

16 Chiropractors found. Showing 1 - 16

Matthew Defroda, D.C Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 1000 Smyrna Clayton Blvd Ste 3, Smyrna, DE 19977 Phone: 302-202-9926

Brooke Mazujian, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 699 S Carter Rd Unit 5, Smyrna, DE 19977 Phone: 302-389-8915

Delaware Back Pain & Sports Rehabilitation Centers Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 29 N East St, Smyrna, DE 19977 Phone: 302-389-2225    Fax: 302-389-1003

Shane Peter Hierlmaier, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 699 S Carter Rd Unit 5, Smyrna, DE 19977 Phone: 302-389-8915

Results Personal Training & Fitness Chiropractor - Nutrition Medicare: Not Enrolled in Medicare Practice Location: 1000 Smyrna Clayton Blvd Ste 1, Smyrna, DE 19977 Phone: 917-945-9406

Pure Wellness Of Smyrna, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 699 S Carter Rd Unit 5, Smyrna, DE 19977 Phone: 302-365-6520    Fax: 302-365-6167

Hetal Chirag Patel, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 29 N East St, Smyrna, DE 19977 Phone: 302-389-2225    Fax: 302-389-1003

Dih Smyrna Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 892 S Dupont Blvd, Smyrna, DE 19977 Phone: 302-653-5525    Fax: 302-653-7010

Zweiacher Chiropractic Services Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 100 S Main St, Suite 204, Smyrna, DE 19977 Phone: 302-653-1188    Fax: 302-653-1182

Concord Health And Rehabilitation,llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 28 N. Dupont Blvd, Concord Health And Rehabilitation, Smyrna, DE 19977 Phone: 302-653-8435    Fax: 302-653-8437

Dr. Greg A Zweiacher, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 100 S Main St, Suite 204, Smyrna, DE 19977 Phone: 302-653-1188    Fax: 302-653-1182

Dr. Kenneth M Decker Ii, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 100 S Main St, Suite 218, Smyrna, DE 19977 Phone: 302-378-8915    Fax: 302-378-8916

Dr. George Bernard Schreppler Iii, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 892 S Dupont Blvd, Smyrna, DE 19977 Phone: 302-653-5525    Fax: 302-653-7010

Dr. Michael G Giambertone, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 699 S Carter Rd Unit 5, Smyrna, DE 19977 Phone: 302-365-6520    Fax: 302-365-6167

Schreppler Chiropractic Offices P.a. Smyrna Delaware Chiropractor Medicare: Medicare Enrolled Practice Location: 892 S Dupont Blvd, Smyrna, DE 19977 Phone: 302-653-5525

Kirk C Evans, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 892 S Dupont Blvd, Smyrna, DE 19977 Phone: 302-653-5525    Fax: 302-653-7010

News Archive

Easter Seals Bay Area urges people to support families living with autism

Ever feel compelled to help a cause you believe in, but just don't know how? By working with Easter Seals Bay Area (bayarea.easterseals.com), you can join the fight for families with autism so they can get the care, guidance and support they need, and help children with autism have the bright future that every child deserves.

Triple-S Management reports consolidated revenues of $584.8 million for first quarter 2014

Triple-S Management Corporation, the leading managed care company in Puerto Rico, today announced consolidated revenues of $584.8 million and consolidated operating income of $10.0 million for the three months ended March 31, 2014.

Hepatic encephalopathy drug XIFAXAN 550 mg tablets receives FDA marketing approval

Salix Pharmaceuticals, Ltd. today announced the U.S. Food and Drug Administration has granted marketing approval for XIFAXAN 550 mg tablets for reduction in risk of overt hepatic encephalopathy recurrence in patients 18 years of age or older. HE is a serious disorder caused by chronic liver failure, resulting in cognitive, psychiatric and motor impairments. This approval was supported by findings from the largest randomized trial of maintenance therapy in HE conducted to date, which assessed the efficacy and safety of XIFAXAN 550 mg tablets and demonstrated a statistically significant and clinically meaningful reduction in the risk of overt HE recurrence.

OXIS International to introduce new ergothioneine-based products for joint health and healthy aging

OXIS INTERNATIONAL, INC. is proud to announce that it will introduce the benefits of Ergothioneine to the consumer market in September 2010 via breakthrough products for joint health and healthy aging. The first products, ErgoFlex® and ErgoPlex®, will initially be marketed via a direct mail offering being developed in partnership with Creative Direct Marketing Group, the leading service provider in the direct mail sector of the direct to consumer channel.

Read more Medical News

› Verified 5 days ago